Anti-inflammatory and antimicrobial effects of nanocatechin in a chronic bacterial prostatitis rat model

Journal of Infection and Chemotherapy

Volumn 17, Issue 2, 2011, Pages 189-194

  Yoon, Byung Il ^a   Ha, U Syn ^a   Sohn, Dong Wan ^a   Lee, Seung Ju ^a   Kim, Hyun Woo ^a   Han, Chang Hee ^a   Lee, Choong Bum ^a   Cho, Yong Hyun ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Animal model; Catechin; Chronic bacterial prostatitis

Indexed keywords

CATECHIN; CIPROFLOXACIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GALLOCATECHIN GALLATE; HYDROXYPROPYLMETHYLCELLULOSE; NANOCATECHIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CHRONIC BACTERIAL PROSTATITIS; CHRONIC PROSTATITIS; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; ESCHERICHIA COLI; GROWTH INHIBITION; MALE; NONHUMAN; PROSTATE BIOPSY; RAT; URINE CULTURE;

EID: 79955905360     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-010-0098-9     Document Type: Article

References (27)

1. Schaeffer AJ. Prostatitis: US perspective. Int J Antimicrob Agents. 1999;11:205-21.
2. Nickel JC, Olson ME, Costerton JW. Rat model of experimental bacterial prostatitis. Infection. 1991;19:126-30.
3. Nickel JC. Prostatitis and related conditions. In: Walsh PC, Reik AB, Vaughan ED Jr, Wein AJ, editors. Campbell's urology. 8th ed. Philadelphia: Saunders; 2002. p. 604-30.
4. Nickel JC. Antibiotics for bacterial prostatitis. J Urol. 2000;163:1560-4.
5. Liao S, Kao YH, Hiipakka RA. Green tea: biochemical and biological basis for health benefits. Vitam Horm. 2001;62:1-94. (Pubitemid 33805701)
6. Sugita-Konishi Y, Hara-Kudo Y, Amano F, Okubo T, Aoi N, Iwaki M, et al. Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157: H7. Biochim Biophys Acta. 1999;1472:42-50.
7. Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998;128:2334-40. (Pubitemid 29012980)
8. Lee YS, Han CH, Kang SH, Lee SJ, Kim SW, Shin OR, et al. Synergistic effect between catechin and ciprofloxacin on chronic bacterial prostatitis rat model. Int J Urol. 2005;12:383-9. (Pubitemid 40965889)
9. Wan YF. Metabolism of green tea catechins: an overview. Curr Drug Metab. 2006;7:755-809.
10. Seo SI, Lee SJ, Kim JC, Choi YJ, Kim SW, Hwang TK, et al. Effects of androgen deprivation on chronic bacterial prostatitis in a rat model. Int J Urol. 2003;10:485-91. (Pubitemid 37239185)
11. Nickel JC, Olson ME, Barabas A, Benediktsson H, Dasgupta MK, Costerton JW. Pathogenesis of chronic bacterial prostatitis in an animal model. Br J Urol. 1990;66:47-54. (Pubitemid 20227997)
12. Cho YH, Lee SJ, Lee JY, Kim SW, Lee CB, Lee WY, et al. Antibacterial effect of intraprostatic zinc injection in a rat model of chronic bacterial prostatitis. Int J Antimicrob Agents. 2002;19:576-82. (Pubitemid 34831664)
13. Jantos C, Altmannsberger M, Weidner W, Schiefer HG. Acute and chronic bacterial prostatitis due to E coli. Description of an animal model. Urol Res. 1990;18:207-11.
14. Lopez-Plaza I, Bostwick DG. Prostatitis. In: Bostwick DG, editor. Pathology of the prostate. New York: Churchill Livingstone; 1990. p. 15-30.
15. Weidner W, Schiefer HG, Krauss H, Jantos C, Friedrich HJ, Altmannsberger M. Chronic prostatitis: a thorough search for etiologically involved microorganisms in 1,461 patients. Infection. 1991;19:119-25.
16. Duclos AJ, Lee CT, Shoskes DA. Current treatment options in the management of chronic prostatitis. Ther Clin Risk Manag. 2007;3:507-12. (Pubitemid 47500001)
17. Curtis CL, Harwood JL, Dent CM, Caterson B. Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov Today. 2004;9:165-72. (Pubitemid 38199962)
18. Chung JH, Han JH, Hwang EJ, Seo JY, Cho KH, Kim KH, et al. Dual mechanisms of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J. 2003;17:1913-5.
19. McKay DL, Blumberg JB. The role of tea in human health: an update. J Am Coll Nutr. 2002;21:1-13.
20. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y. Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr. 2004;134:38-42. (Pubitemid 38057420)
21. Yoda Y, Hu ZQ, Zhao WH, Shimamura T. Different susceptibilities of Staphylococcus and Gram-negative rods to epigallocatechin gallate. J Infect Chemother. 2004;10:55-8. (Pubitemid 38298046)
22. Isogai E, Isogai H, Hirose K, Hayashi S, Oguma K. In vivo synergy between green tea extract and levofloxacin against enterohemorrhagic Escherichia coli O157 infection. Curr Microbiol. 2001;42:248-51.
23. Kim BS, Kim MS, Lee HB. Application of HPMC (hydroxypropyl methylcellulose) as drug delivery carrier system. Polym Sci Technol. 2007;18:549-53.
24. Kim DM. Nanotechnology applicable to nanofood materials and traditional food products at the age of well-being. Mon Food Indus. 2006;24:68-80.
25. Kim DM, Cho GS. Nanofood and its materials as nutrient delivery system (NDS). Agric Chem Biotechnol. 2006;49:39-47.
26. Kim DM, Lee GD, Shin YK. Clinical analysis of lutein in taking HPMC-lutein nanoparticle(nanofood) and in taking raw or cooked vegetables. Tissue Eng Regen Med. 2006;3:464-71.
27. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med. 1992;21:334-50.